Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheumatologists Can Guide Patients During Pregnancy, Family Planning

Vanessa Caceres  |  September 27, 2022

Otherwise, patients are most likely guided by information given by the doctors they see more often, such as general practitioners or pediatricians.

Guiding Health Pre-Pregnancy

Another area discussed during the episode is medication choices made before a woman becomes pregnant. Speakers addressed research from Bortoluzzi et al., which was published in 2021 in Arthritis Care & Research.4 This topic is a key area because of the increased risk of adverse pregnancy outcomes when a patient’s disease is very active. Changing medications if needed to aim for quiet disease is often more useful before pregnancy than trying to do it after a woman is pregnant, Dr. Sammaritano says.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Quiet disease can help lead to better outcomes for both the mother and the baby. This approach applies to both lupus and RA, Dr. Sammaritano says.

This finding increases the importance of rheumatologists discussing family planning with all their patients early because certain medications can be started before the patient gets pregnant.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“Everything we give our patients impacts this area, and we need to be involved from the beginning,” Dr. Sammaritano says. This includes ensuring patients are using contraception if they take medications that are not considered safe during pregnancy.

Dr. White says she has been fortunate to have a rheumatologist who regularly addressed this topic during her pregnancies. It’s also important to address these concerns with male patients of reproductive age, she adds, including reviewing which medications they can use safely if they are trying to father a child.


Vanessa Caceres is a medical writer in Bradenton, Fla.

References

  1. Sammaritano LR, Bermas BL, Chakravarty EL, Chambers C, Clowse MEB, Lockshin MD, et al. 2020 American College of Rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases. Arthritis Rheumatol. 2020 Apr;72(4):529–556.
  2. Talabi MB, Eudy AM, Jayasundara MJ, et al. Tough choices: Exploring medication decision-making during pregnancy and lactation among women with inflammatory arthritis. ACR Open Rheumatol. 2021 Jul;3(7):475–483.
  3. Mills BS, Bermas BL. Improving knowledge of lactation compatibility of antirheumatic medications among providers who care for patients with rheumatic disease. ACR Open Rheumatol. 2021 Jan;3(1):50–54.
  4. Bortoluzzi A, Andreoli L, Carrara G, et al. Improved pregnancy outcomes in patients with rheumatoid arthritis who followed an ideal clinical pathway. Arthritis Care Res (Hoboken). 2021 Feb;73(2):166–172.

More Episodes

A new episode of ACR on Air comes out twice a month. Listen to this full episode and others online at acronair.org. Or download and subscribe wherever you get your podcasts.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:Conditions Tagged with:ACR on AirACR on Air podcastpregnancypregnant women

Related Articles

    Challenges in Reproductive Health in Rheumatic Disease

    July 11, 2022

    In light of new challenges to individuals’ reproductive rights and the known challenges of clinical management of rheumatic disease patients during pregnancy, we review the current state of reproductive rheumatology and the management of patients with rheumatic disease during pregnancy.

    A Better Family Plan

    October 1, 2007

    How to minimize the risks of pregnancy for women with SLE

    AndreyCherkasov / Shutterstock.com

    Rheumatic Disease Does Not Preclude Pregnancy

    November 9, 2017

    Preconception planning is essential to help women with autoimmune disease have optimal pregnancy outcomes. Unplanned pregnancy can also negatively impact disease course in some patients. Yet many rheumatologic patients of childbearing age do not receive adequate contraception or prepregnancy education and counseling. Rheumatologists must work collaboratively with other healthcare providers to make sure rheumatic patients…

    Rheumatologists Should Discuss with Patients Use of Immunomodulatory Agents During Pregnancy

    November 16, 2016

    The decision to continue or discontinue immunomodulatory medications during pregnancy is a difficult one for both patients and physicians. On the one hand, when left untreated, rheumatic conditions can cause harm to an unborn child, as well as to the pregnant mother. On the other hand, medications can be harmful to a developing fetus. In…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences